Introduction
The enzymatic conversion of relatively non-toxic prodrugs to cytotoxic derivatives is a widely investigated strategy for cancer gene therapy, often called gene (or virus-)-directed enzyme prodrug therapy (GDEPT). A variety of enzyme/prodrug combinations have been described, including nitroreductase (NTR)/5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954). The NTR enzyme encoded by the nfsB gene of Escherichia coli (E. coli) was originally recognized for its role in sensitizing the bacteria to the antibiotic nitrofurazone. 1 This NTR was later shown to convert the prodrug CB1954 to a potent DNA-crosslinking agent, 2 leading to the investigation of this combination for cancer gene therapy. [3] [4] [5] [6] [7] [8] Expression of NTR from a replication-defective adenovirus can increase the sensitivity of carcinoma cells to CB1954 by 41000-fold 7, 9 and this combination has entered clinical trials. [10] [11] [12] [13] The cell-cycle independence of CB1954-mediated toxicity may have advantages over the S-phase-dependent toxicity of ganciclovir (GCV) or 5-fluorocytosine (5FC) to cells expressing herpes simplex virus thymidine kinase (HSV-TK) or cytosine deaminase (CD), respectively. 3, 7 The activity of prodrug-activating enzymes with their prodrug substrates is often suboptimal. At the clinically achievable dose of CB1954, its peak serum concentration is B5-10 mM, 10 about 100-fold below the reported K m for NTR. 2 This limits the amount of prodrug that can be activated, and hence limits cell killing. Engineered NTR variants with improved ability to activate CB1954 would offer substantial clinical benefit. In a previous study, 14 we individually randomized nine positions within the active site chosen on the basis of the crystal structure, 15 and screened these by replica plating of E. coli at a range of CB1954 concentrations. Single amino-acid substitutions at six of these positions were found to increase the sensitivity of the bacteria to CB1954 by up to B5-fold. One of these mutants, F124K, was shown to be about fivefold more potent than WT-NTR in sensitizing human carcinoma cells to CB1954. 14 Improved mutants of HSV-TK and CD for use in GDEPT have previously been generated by first selecting mutant libraries in E. coli for ability to utilize the natural substrates (thymidine or cytosine, respectively), before screening the clones for susceptibility to the appropriate prodrug. 16, 17 This indirect approach is unsuitable for NTR, as the natural substrate is unknown and, surprisingly, no substrate has been described for which reduction by NTR provides a survival advantage. Development of improved prodrug-activating enzymes would be greatly facilitated by a direct, positive selection for improved prodrug activation. However, as activated prodrugs are cytotoxic, prodrug activation leads to death, rather than preferential survival, of cells expressing improved enzymes. In this paper, we show that the SOS-mediated induction of lambda lysogens into lytic cycle allows the direct, positive selection of phages encoding improved prodrug-activating enzymes.
In E. coli, DNA damage activates the SOS response, which leads to the induction of DNA repair mechanisms. 18 This is initiated by the RecA protein, which also activates proteolytic cleavage of the cI transcriptional repressor protein of bacteriophage lambda (l). The cI repressor controls the switch between the lytic cycle and the lysogenic phase of the bacteriophage. 19 In lysogens, the lambda genome is integrated into the bacterial chromosome, cI inhibits transcription from lytic cycle promoters, and the prophage is stably transmitted to subsequent generations of bacteria. Proteolytic cleavage of the cI repressor, owing to activation of the SOS response in a lysogen, results in de-repression of the lytic cycle promoters. This leads to prophage excision, replication and bacterial lysis, releasing multiple progeny phage particles. 20 Here, we demonstrate that activation of CB1954 by NTR triggers the lambda lytic cycle in lysogenized, recA + E. coli. This allows enrichment of phages encoding improved NTRs from mixed populations. The power of the approach is demonstrated by the selection of substantially improved NTR variants from a library of 6.8 Â 10 5 independent clones, and we validate the best of these in a human cancer cell line.
Results
The selection strategy is illustrated in Figure 1 . The lambda vector lJG16C2 (Figure 1a ) contains a kanamycin resistance cassette for antibiotic selection of lysogenized E. coli and the NTR gene inserted under the control of the Ptac promoter.
14 In lysogenized E. coli (Figure 1b) , expression of NTR from the integrated prophage allows prodrug activation, triggering the SOS response and switching the lambda into lytic cycle. Figure 1c shows how this can be incorporated into an iterative selection strategy.
NTR-and CB1954 dose-dependent activation of lambda lytic cycle
To test whether CB1954 activation by NTR would cause entry of lambda lysogens into the lytic cycle, lysogens of the recA + , nfsB À E. coli strain UT5600 were generated using lJG16C2 (which expresses WT-NTR), the empty vector (lJG3J1), and the phage containing the improved F124N-NTR mutant. This mutant confers five-to sixfold greater sensitivity to CB1954 than to WT-NTR in E. coli. 14 These lysogens were transiently (15 min) exposed to a range of CB1954 concentrations and then incubated for 1 h before analysis of cell viability (Figure 2a ) and phage release (Figure 2b ). For lysogens carrying the empty vector, increasing CB1954 concentration from 0 to 500 mM caused no reduction of cell viability, and the low background level of the phage release remained un- Figure 1 Using the SOS response to select lambda vectors encoding improved prodrug-activating enzymes. (a) Schematic map of lJG16C2. The lambda vector (thick line) is shown integrated, via its att sites, into the E. coli chromosome (thin line). P L , P R , lytic cycle promoters. The cI repressor is encoded in the immunity (imm) region. The NTR gene is inserted between SfiI sites downstream of the IPTG-inducible P tac promoter. KanR, kanamycin resistance gene. (b) Mechanism of SOS induction. NTR is expressed from the integrated prophage in the lysogenized E. coli host. The prodrug CB1954 is activated by NTR, generating the active species that causes interstrand crosslinks in DNA. This leads to stalling of DNA replication forks, exposing single-strand DNA that activates RecA and hence the SOS response. Activated RecA causes proteolysis of the lambda cI repressor, allowing transcription of lytic cycle genes. This leads to excision and replication of the lambda genome, assembly of new phage particles and host cell lysis. (c) Selection for phages encoding more active prodrug-activating enzymes. E. coli are infected with a lambda library containing mutated NTR genes, and lysogenized bacteria are selected with kanamycin. When transiently exposed to a limiting concentration of prodrug, only lysogens expressing the more active variants of the enzyme activate sufficient prodrug to induce the SOS response, and thus be induced into lytic cycle. The harvested phages are therefore enriched in lambda encoding improved prodrug-activating enzymes. The efficiency of the selection is improved by performing multiple cycles of selection, using the recovered phages to generate lysogens for the next round. The selected phage population and individual clones are analysed for their ability to sensitize E. coli to prodrug. The selected phage populations could also be used for further mutagenesis or recombination via DNA-shuffling, between cycles of selection.
Selection of improved nitroreductases CP Guise et al changed. Lysogens expressing WT-NTR showed a dosedependent decrease in plating efficiency, with nearcomplete loss of viability at 500 mM CB1954. This was mirrored by a dose-dependent increase in phage release, reaching a titre more than 50-fold higher than the empty vector at 500 mM CB1954. Lysogens expressing F124N-NTR were almost entirely killed by 100 mM CB1954, and the titre of the released phage increased steeply at low prodrug concentrations, peaking at 100 mM CB1954. The gradual decrease in titre of F124N phage above 100 mM CB1954 may be due to increased DNA damage by higher levels of activated prodrug.
This shows that CB1954 activation by NTR triggers phage release from lysogens. The titre of released phages depends upon the prodrug concentration and the activity of the enzyme, suggesting that this could allow selection for more active enzymes.
Positive selection of NTR-expressing phages from a mixed population by CB1954 exposure
In mammalian systems, activated CB1954 can diffuse from NTR-expressing cells into the surrounding medium, leading to 'bystander' killing of other cells. 4, 5, 8, 21 Such an effect in bacteria could potentially reduce the efficiency of phage selection from a mixed population, as induction of the lytic cycle would be less dependent upon the NTR expressed from the resident prophage in that cell. To determine whether phage encoding active NTRs could be enriched from a mixed population, we derived two mixed populations of lysogens, using 90% empty vector and 10% phages encoding either WT or F124N-NTR. Half of each culture was transiently exposed to 100 mM CB1954 (shown in Figure 2b to be the optimal concentration for F124N phage release, but suboptimal for WT-NTR). To reduce possible bystander effects, prodrug exposure was performed at relatively low bacterial culture density (OD 600 0.1). The released phages were titred, and analysed by dot-blotting and DNA hybridization for the presence of the NTR transgene ( Figure 3 ). For the phage mixture containing WT-NTR, CB1954 treatment resulted in only a modest (37%) increase in titre (from 5.1 to 7.0 Â 10 4 PFU/ml), but a threefold increase in the proportion of NTR-containing plaques from 3/50 to 9/50. For the F124N-NTR mixture, a much greater increase in phage release was observed (339%, from 4.1 Â 10 4 to 1.8 Â 10 5 PFU/ml) and the proportion of NTR-containing plaques increased to 39/50, in the CB1954-treated cultures.
These results established that phages encoding active NTRs can be preferentially recovered from mixed populations of lysogens. The low dose of CB1954 used in this experiment allowed some enrichment of lysogens expressing WT-NTR and resulted in significantly greater enrichment of the more active, F124N-NTR variant. Thus, when the dose of prodrug is limiting, there is greater selection for more active enzymes.
Selection of improved NTR variants from libraries randomized at N71 or F124
To test the ability to select improved enzymes from more complex libraries of NTR mutants, we used small libraries of lambda phages containing NTR genes in which either the N71 or F124 codon was randomized. We targeted these residues because, in our previous screen, we had found that only one substitution at N71 Figure 2 Analysis of prodrug dose required to activate lysogens into lytic cycle. Cultures of E. coli UT5600 were lysogenized with empty vector (lJG3J1), or the vector expressing either WT-or F124N-NTR. Cultures were transiently exposed to the indicated concentrations of CB1954 as described in Materials and methods. 
Selection of improved nitroreductases
CP Guise et al (to serine) results in significant (B3-fold) improved sensitization of E. coli to CB1954, whereas 13 different substitutions at F124 give three-to sixfold improvement. 14 Three successive rounds of selection were carried out on each library, with the phages harvested from one round being used to derive the lysogens for the next cycle. At each stage the lysogens were analysed for CB1954 sensitivity by plating on agar containing a range of CB1954 concentrations (Figure 4 ). For WT-NTR lysogens, plating efficiency drops below 10% at 160 mM CB1954, whereas lysogens without NTR show no reduction at 500 mM (Figure 4a) . For the N71 library (Figure 4b ), before selection 75% of lysogens could form colonies at up to 200 mM CB1954, consistent with the expectation that most mutations would be detrimental to activity. After three rounds of selection, plating efficiency was reduced to o25% at prodrug concentrations X75 mM, suggesting enrichment of NTRs better able to activate CB1954. Forty plaques of the selected phages were picked and their NTR genes sequenced. In 37 of the sequences, N71 was replaced with serine, whereas curiously, the remaining three contained stop codons at this position. The selection of N71S concurs with our previous identification of serine as the best amino acid at this position for CB1954 activation, 14 and shows that this can be efficiently selected from a library.
For the F124 library, plating efficiency before selection was reduced to B50% at CB1954 concentrations above 50 mM (Figure 4c) , as expected because a high proportion of F124 substitutions are more active than WT.
14 The sensitivity of the lysogen population to CB1954 was markedly increased during the selection. Sequencing of NTR genes from 31 plaques after three rounds of selection identified 12 encoding F124H, 7 F124N, 5 F124M, 4 F124K, and one each of F124A, F124V, and F124S, all substitutions previously found to give 43-fold improved sensitization to CB1954. 14 
Identification of novel, highly improved NTR mutants through selection of a large combinatorial library
A lambda library was generated containing NTR genes each with randomized codons at three out of five sites. Random base substitutions at codon F124 were combined with substitutions at either S40 or T41, and with substitutions at either F70 or N71, giving a total of 64 Â (64+64) Â (64+64) ¼ 1 048 576 possible nucleotide sequence combinations. The phage packaging reaction generated 6.8 Â 10 5 independent clones. Before selection, B90% of the lysogens were resistant to 400 mM CB1954 (Figure 5a ), indicating that the great majority of mutants were impaired in CB1954 activation. Following three cycles of selection with 100 mM CB1954, the IC 50 of the library (prodrug concentration giving 50% reduction in plating efficiency) decreased to 24 mM CB1954. Four further rounds of selection were performed using 50 mM CB1954, reducing the IC 50 of the lysogen population to 17 mM. Finally, three rounds of selection were performed using 30 mM CB1954, giving an IC 50 of 7 mM. At this point, no colonies of lysogens grew at 25 mM CB1954.
The NTR genes were sequenced from 103 plaques obtained after seven rounds of selection, and from an additional 30 plaques after 10 rounds of selection. In total, 48 different NTR mutants were identified, and these were analysed by replica plating at different concentrations of CB1954 to estimate sensitivity; 46 of these conferred greater sensitivity than WT-NTR. The IC 50 s of selected mutants were determined, and examples are shown in Figure 5b . The amino-acid substitutions, number of clones and distinct nucleotide sequence variants for each, and the CB1954 sensitivities of the mutants are listed in Supplementary Information (Table 3) for mutants obtained after seven rounds of selection, and in Table 1 for those obtained after 10 rounds.
The only single mutant isolated was F124N, in two distinct clones after seven rounds of selection. This was 14 Double and triple mutants made up 37/133 and 79/133 of the analysed clones, respectively, and there were 10 quadruple mutants.
Seventeen different double mutants were identified. Twelve of these were combinations of S40A, most with a range of F124 substitutions. Six were combinations of T41L, I or N with F70 or F124 substitutions, and four were combinations of N71S with different F124 substitutions. The best double mutants, S40A/F124A and N71S/ F124T, both gave IC 50 s of B18 mM CB1954.
Most of the 23 different triple mutants fell into two categories. Ten were combinations of S40A with a variety of substitutions at F70 and F124. The best of these (S40A/ F70V/F124A) has an IC 50 of 16 mM CB1954, a slight improvement on the S40A/F124A double mutant. Two clones were obtained combining S40A with N71S and F124N or T; the S40A/N71S/F124T combination gave an IC 50 of 13 mM CB1954. Ten types of mutant combined N71S with substitutions of T41 and F124. Six of these (accounting for 43/133 sequenced clones) incorporated T41Q. T41Q/N71S/F124T was the best mutant identified, with an IC 50 of B3 mM CB1954, about 50-fold better than WT (Figure 5b) .
The seven distinct quadruple mutants each incorporated one or two mutations at non-targeted sites, presumably owing to polymerase chain reaction (PCR) errors. The best of these was D17N/T41N/N71S/F124T with an IC 50 of 12 mM CB1954, less good than the corresponding T41N/N71S/F124T triple mutant (IC 50 9 mM, the second-best mutant identified).
It is notable that of the amino-acid substitutions present in the best mutant selected (T41Q/N71S/ F124T), only N71S is also optimal as a single mutant (IC 50 55 mM CB1954).
14 F124T (IC 50 72 mM) is about twofold better than WT (IC 50 143 mM) but 12 other single F124 substitutions are even better, 14 whereas T41Q is detrimental as a single mutant (IC 50 350 mM). The three corresponding double mutants were found to have IC 50 s from 18 to 31 mM; the fold improvement (decrease in IC 50 ) for each double mutant is greater than the product of the improvements of the corresponding single mutants, thus each combination acts cooperatively ( Table 2 ). The T41Q/N71S/F124T triple mutant (IC 50 3 mM) shows further synergy among the three substitutions. In WT-NTR, both T41 and F124 can interact with bound ligand, the phenyl ring of F124 being displaced to accommodate aromatic ligands. 15, 22 Changing T41 to the longer glutamine may allow additional, favourable interactions with CB1954, particularly when the bulky F124 is replaced by threonine. N71 hydrogen bonds to the flavin mononucleotide (FMN) cofactor, 15 and we propose that the N71S substitution probably affects the FMN redox potential rather than contacting bound CB1954. The ability to identify such improved enzymes with multiple, synergistic amino-acid substitutions is greatly facilitated by a direct, positive selection strategy, applied to a large library of mutants.
Sensitization of carcinoma cells to CB1954 by the T41Q/N71S/F124T NTR mutant
The best, triple mutant NTR was inserted into a replication-defective adenovirus vector for testing in human carcinoma cells in comparison with WT-NTR. As shown in Figure 6 , the T41Q/N71S/F124T NTR was significantly more effective at sensitizing SKOV3 cells to CB1954 than WT-NTR. At multiplicities of infection (MOI) of 30 or 10 PFU/cell, the IC 50 was 0.84 or 2.3 mM CB1954, respectively, for T41Q/N71S/F124T versus 33 or 186 mM CB1954 for WT-NTR, corresponding to 40-to 80-fold greater sensitization by the virus expressing the triple mutant. Comparison of the level of enzyme expression by Western blot (not shown) indicated that the triple mutant was expressed at a level 2.5-to 3-fold higher than WT-NTR, which should contribute proportionately to its greater efficacy; however, the major F70V F124A  1  1  16  T41N N71S F124T  6  2  9  T41N N71S F124N  1  1  12  T41Q N71S F124L  1  1  15  T41Q N71S F124T  6  2  3  T41Q N71S F124N  6  2  13  T41Q N71S F124V  2  1  23  T41L S43A F70E F124Y  1  1 27.5
Selection of improved nitroreductases CP Guise et al contribution can be attributed to improved catalytic activity of the enzyme.
Discussion
We have demonstrated the development and application of a novel, direct, positive selection for improved prodrug activation by E. coli NTR. This exploits the lysogenic life cycle of bacteriophage lambda, and relies upon triggering of the SOS response by RecA protein in response to DNA lesions, switching lambda lysogens into the lytic cycle. 18, 23, 24 It was reported previously that CB1954 could activate the SOS response in E. coli. 25 Consistent with this, we have shown that CB1954 activation by NTR in E. coli lysogens causes dose-dependent release of infectious bacteriophage particles, at titres up to 50-fold above the spontaneous background (Figure 2 ). Single-stranded DNA is required for RecA activation; 18 this is presumably exposed at replication forks that have stalled at inter-strand DNA crosslinks caused by activated CB1954. Use of limiting CB1954 concentrations allows preferential enrichment of phages encoding more active enzymes (Figure 3) . Figures 4 and 5 demonstrate the progressive improvement in IC 50 of the lysogen populations through multiple, sequential rounds of selection, as the initially rare, improved variants from the starting library become progressively enriched. The phages selected in one cycle are used to generate lysogens for the next round, and as indicated in Figure 1c , these phage populations enriched in improved enzyme variants would also be suitable substrates for further mutagenesis or DNA shuffling 26 of the enzyme gene, allowing further directed evolution of the enzyme through multiple rounds of selection.
Both HSV-TK and E. coli CD have previously been engineered for improved prodrug activation. 16, 17, 27 In the absence of a direct positive selection for prodrug utilization, the plasmid libraries were first selected for activity with the natural enzyme substrates, eliminating the majority of inactive variants, before screening the remaining clones individually for activation of the relevant prodrug. Surprisingly, the best mutants showed relatively little improvement in activity with their prodrugs (the specificity constant k cat /K m was improved at most B2.5-fold), whereas their activity with the natural substrates, thymidine or cytosine, was greatly impaired (k cat /K m reduced B20-to 200-fold). 28, 29 Thus, the substantial improvements obtained in cell sensitization to the prodrugs by the mutant enzymes appear to result largely from reduced competition from the intracellular pools of thymidine or cytosine. An alternative approach to enzyme improvement involved robotic screening of 10 000 clones generated by DNAshuffling of the TK genes from HSV-1 and HSV-2. 30 After four cycles of shuffling and screening, two clones were obtained with bacterial IC 50 s for AZT (zidovudine) 32-fold lower than the more active starting enzyme (HSV-1 TK). Relative to HSV-1 TK, the k cat /K m for AZT was increased just 1.5-fold, whereas that for thymidine was 30-fold reduced. 30 Our lambda-based strategy facilitated the direct, positive selection of improved mutants from an initial library of 680 000 clones without the need for robotics. The best NTR mutant selected in this study, T41Q/ N71S/F124T, had an IC 50 in E. coli of just 3 mM CB1954, about 50-fold lower than WT. Kinetic studies (Jarrom et al. in preparation) show that its specificity constant k cat /K m for CB1954 is increased almost 50-fold compared with WT-NTR. For this mutant, CB1954 is now a better Expected fold improvement for the double and triple mutants was calculated as the product of the fold improvements for the corresponding contributory single mutants and thus assumes that there is no synergy. e The synergy factor was calculated by dividing the actual fold improvement by the expected fold improvement. Selection of improved nitroreductases CP Guise et al substrate than the antibiotic nitrofurazone, for which k cat /K m is unchanged. The 50-fold improvement achieved, selectively for the CB1954 substrate, with this unexpected combination of substitutions emphasizes the advantage of a direct, positive selection for improved prodrug activation, able to utilize a large combinatorial library. Lambda is an efficient vector for the construction of libraries containing up to B10 7 independent clones, 31 and the diversity in such large libraries could be further increased via application of additional mutagenesis or DNA shuffling, interspersed between cycles of selection ( Figure 1c) . It has been reported that 5-fluorouracil (the product of 5FC activation) can induce lambda lytic cycle; 19 thus, CD/5FC and other prodrug activation systems that inhibit DNA replication directly or indirectly, such as TK/GCV, might also be amenable to improvement via this selection strategy.
The combination of WT-NTR (expressed using a replication-defective adenovirus) and CB1954 has entered gene therapy clinical trials. 12, 13 To begin to evaluate the T41Q/N71S/F124T mutant in human cancers, we used an adenovirus vector to express this mutant or WT-NTR in SKOV3 ovarian carcinoma cells. At MOIs of 30 or 10 PFU/cell, the IC 50 obtained with the T41Q/N71S/ F124T NTR mutant was 40-to 80-fold lower than with WT-NTR. One contribution to this differential appears to be that the level of the mutant NTR in the cells was 2.5-to 3-fold higher than WT-NTR at the same MOI, which is expected to contribute proportionately to the sensitization obtained; nevertheless, it is clear that the major factor in the increased sensitization to CB1954 is the improved catalytic efficiency of the mutant enzyme. These results suggest that the T41Q/N71S/F124T NTR mutant obtained in this study using the lambda selection method we have described could result in significantly improved clinical efficacy of the NTR/CB1954 combination. The selection system could also contribute more widely to the development of a new generation of prodrug-activating enzymes specifically adapted for their prodrug substrates.
Materials and methods

Bacterial strains and lambda vectors
The RecA + E. coli strain UT5600 (obtained from the E. coli Genetic Stock Center, Yale) has a deletion that removes the nfnB/nfsB gene encoding NTR. The lambda vector lJG3J1 and its derivatives expressing WT-NTR (lJG16C2, Figure 1a ) and F124N-NTR (lJG131I154) were described previously. 14 
Lysogen generation
Cultures of E. coli UT5600 in 50 ml Luria-Bertani (LB) medium were shaken at 371C until reaching an OD 600 of 0.5, centrifuged at 450 g for 10 min at 41C, resuspended in 25 ml 10 mM MgSO 4 , and stored at 41C for up to 7 days. To generate lysogens, 100 ml of the bacteria were mixed with 100 ml of 10-fold serial dilutions of phage stock, incubated at 371C for 30 min, then plated on LB agar containing 30 mg/ml kanamycin. Plates were incubated overnight at 371C for colony growth.
CB1954 dose-response for induction of lysogens
Cultures of lysogens were grown at 371C with shaking in LB/kanamycin, to an OD 600 of 0.1. Isopropylthiogalactoside (IPTG) was then added to a final concentration of 0.1 mM to induce NTR expression. At OD 600 0.5, 1 ml of the culture was added to 4 ml of pre-warmed LB/ kanamycin containing 0.1 mM IPTG, 62.5 mM Tris pH 7.5 and 0-625 mM CB1954 (kindly provided by ML Laboratories, Keele, UK). After shaking for 15 min at 371C, 10 ml of each culture was added to 10 ml fresh, pre-warmed LB, and incubated for a further period, optimized as 1 h, to allow lysogens induced by the prodrug exposure to complete their lytic cycle. To determine cell viability, cultures were diluted 1000-and 10 000-fold, 0.1 ml was spread onto duplicate LB/kanamycin plates and incubated overnight at 371C before counting colonies. To quantitate phage release, 1 ml of culture was centrifuged at 10 000 g for 5 min to remove lysogens, and the titre of the supernatant was analysed by standard plaque assay. 32 
Dot-blot to identify NTR-containing phage
Individual phage plaques were picked and spotted onto a fresh lawn of E. coli UT5600, to create an array of plaques. Plaques were transferred to Hybond-N membrane (Amersham, Chalfont St Giles, UK), denatured, 32 and then crosslinked to the membrane by UV exposure using a Stratalinker (Stratagene, La Jolla, CA, USA). A NTR DNA probe was labelled using the Amersham ECL direct nucleic acid labelling and detection system, hybridized to the filter that was then washed, and the bound probe was detected, according to the manufacturer's instructions.
Single codon library construction and selection
The libraries with randomized codons at position N71 or F124 were constructed as described previously.
14 For example, the N71 codon was randomized by PCR using a primer containing NNN (where N is A, C, G or T) at codon 71 to amplify the 5 0 portion of the gene, and subsequent PCR-mediated recombination with a 3 0 gene fragment commencing at codon 72. The final full-length PCR product was digested with SfiI and ligated between the SfiI sites of lJG3J1. The two SfiI sites have nonmatching 5 0 extensions, thus ensuring that the inserts are in the correct orientation. The ligated DNA was packaged using Gigapack III plus packaging extract (Stratagene) and was titred. Packaged phage was amplified by generating a plate lysate. 32 To generate lysogens, 1 Â 10 8 PFU was used to infect an excess of E. coli UT5600. Following 30 min incubation at 371C cultures were diluted to 10 ml with pre-warmed LB/kanamycin and grown at 371C with shaking. The cultures were grown and exposed to 100 mM CB1954, as described above. After 15 min with CB1954, the cultures (5 ml) were diluted with 45 ml of pre-warmed LB and centrifuged at 1300 g for 5 min. The cell pellets were resuspended in 5 ml fresh LB, incubated for 1 h at 371C, and then released phages were separated from remaining E. coli lysogens by filtration through a 0.2 mm Acrodisc filter (Pall). The titre of the harvested phages varied from 2.3 Â 10 7 to 1.7 Â 10 8 PFU/ml, and between 1 Â 10 7 and 1 Â 10 8 PFU was used to infect fresh UT5600 cells for subsequent rounds of selection. The packaging reaction yielded a total of 6.8 Â 10 5 independent phages. As the efficiency of generating lysogens is only B1%, to preserve the diversity in the library it was first amplified by a round of lytic growth, to give 5 ml at 3.6 Â 10 9 PFU/ml, before using 10 8 PFU to generate lysogens. Selection was carried out as described for the N71 and F124 libraries, using 100 mM CB1954 for rounds 1-3, 50 mM for rounds 4-7 and 30 mM for rounds [8] [9] [10] . The titre of the harvested phages varied from 1 Â 10 7 to 1.1 Â 10 8 PFU/ml, and between 1 Â 10 7 and 1 Â 10 8 PFU was used to infect fresh UT5600 cells for subsequent rounds of selection.
Analysis of selected phages
Plaques of selected phages were picked for analysis. Primers binding to the lambda genome flanking the NTR insert were used to amplify the NTR DNA for each plaque, and the PCR fragment was sequenced. Representative phages containing each NTR variant were used to generate lysogens, and tested for CB1954 sensitivity by replica plating from liquid culture in 96-well plates onto LB agar containing 30 mg/ml kanamycin, 0.1 mM IPTG, 50 mM Tris pH 7.5, and a range of CB1954 concentrations. The more sensitive lysogens were analysed further in a colony-forming assay to determine their IC 50 .
Colony forming IC 50 assays
Lysogens were grown in LB/kanamycin; at an OD 600 of 0.1, IPTG was added to a final concentration of 0.1 mM to induce NTR expression. At OD 600 0.5, the culture was diluted 250 000-fold, and 100 ml was spread onto LB agar plates containing 50 mM Tris pH 7.5, 0.1 mM IPTG, 30 mg/ml kanamycin, and a range of CB1954 concentrations. Colonies were counted after overnight incubation at 371C. The plating efficiency at each prodrug concentration was calculated as a percentage of the number of colonies obtained in the absence of prodrug. The IC 50 (prodrug concentration required for 50% reduction in colony number) was estimated by interpolation.
Adenovirus vectors and carcinoma cell sensitization assay
The E1,E3-deleted adenovirus vectors vPS1306A and vPS1308A express WT or T41Q/N71S/F124T NTR, respectively, from the cytomegalovirus promoter. Their design is similar to that of vPS1233 14 except that they encode human granulocyte/macrophage colony-stimulating factor (GM-CSF) (rather that enhanced green fluorescent protein), linked by an internal ribosome entry site downstream of the NTR inserts, in the same expression cassette. Expression of hGM-CSF is not expected to influence the differential prodrug sensitization by the enzymes and was not monitored in these experiments. Experiments to determine the sensitization of SKOV3 cells to CB1954 by the viruses were performed as described, 14 except that the prodrug exposure was reduced to 16 h.
Abbreviations
NTR, nitroreductase; CB1954, 5-(aziridin-1-yl)-2,4-dinitrobenzamide
